Cancer Clinical Investigation

Search results

• NYC Mayor Eric Adams Joined Top Biomedical Researchers to Usher in the Center for Engineering and Precision Medicine at Hudson Research Center at 619 West 54th Street

  Jonathan Dordick, Deepak Vashishth,, Dennis Charney & Priti Balchandani

  29/03/23

  1 item of Media coverage

  Press/Media

• Investigators at Icahn School of Medicine at Mount Sinai Report Findings in Clinical Oncology (Targeted Degradation of Prc1 Components, Bmi1 and Ring1b, Via a Novel Protein Complex Degrader Strategy)

  Brandon Dale, Md Kabir, Yue Zhong & Jian Jin

  27/03/23

  1 item of Media coverage

  Press/Media

• Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

  Samir Parekh

  22/03/23

  1 item of Media coverage

  Press/Media

• Findings from Icahn School of Medicine at Mount Sinai Yields New Findings on Non-Small Cell Lung Cancer (The Benefits and Harms of Adjuvant Chemotherapy for Non-small Cell Lung Cancer In Patients With Major Comorbidities: a Simulation Study)

  Rajwanth Veluswamy, Cardinale Smith, Minal Kale, Keith Sigel & Amanda Leiter

  22/03/23

  1 item of Media coverage

  Press/Media

• New Findings in Multiple Myeloma Described from Icahn School of Medicine at Mount Sinai (Dissecting and Targeting Noncanonical Functions of Ezh2 In Multiple Myeloma Via an Ezh2 Degrader)

  Jing Liu, Jun Wang & Jian Jin

  20/03/23

  1 item of Media coverage

  Press/Media

• Anal cancer in the United States linked to AIDS and inequalities

  Karyn Goodman

  17/03/23

  1 item of Media coverage

  Press/Media

• Bispecific Antibodies Promise to be ‘Transformative’ in Multiple Myeloma

  Ajai Chari

  17/03/23

  1 item of Media coverage

  Press/Media

• Data on Liver Cancer Detailed by Researchers at Icahn School of Medicine at Mount Sinai (Unannotated Small Rna Clusters Associated With Circulating Extracellular Vesicles Detect Early Stage Liver Cancer)

  Parissa Tabrizian, Robert Sebra, Myron Schwartz, Navneet Dogra, Augusto Villanueva Rodriguez, Gabriela Hernandez Meza, Carlos Cordon-Cardo,, Kimaada Allette, Teresa Garcia Lezana, Samuel Waxman, Amon Asgharpour, Josep Llovet, Douglas Dieterich, Bojan Losic & Mehmet Eren Ahsen

  16/03/23

  1 item of Media coverage

  Press/Media

• Protagonist Therapeutics Announces Highly Statistically Significant Results from the Randomized Withdrawal Portion of the REVIVE Study of Rusfertide in Polycythemia Vera

  Ronald Hoffman

  15/03/23

  85 items of Media coverage

  Press/Media

• Protagonist Therapeutics Announces Highly Statistically Significant Results from the Randomized Withdrawal Portion of the REVIVE Study of Rusfertide in Polycythemia Vera

  Ronald Hoffman

  15/03/23

  1 item of Media coverage

  Press/Media

• FABA holding virtual workshop on drug discovery from March 13

  E. Premkumar Reddy

  11/03/23

  1 item of Media coverage

  Press/Media

• Australia Patent: Application for 'Serine threonine kinase (AKT) degradation / disruption compounds and methods of use' Lapses

  Ramon Parsons, Jing Liu & Jian Jin

  10/03/23

  1 item of Media coverage

  Press/Media

• -BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B/2A TRIAL EVALUATING BEMCENTINIB IN 1ST LINE NON-SMALL CELL LUNG CANCER WITH STK11 MUTATIONS

  Rajwanth Veluswamy

  10/03/23

  2 items of Media coverage

  Press/Media

• Australia Patent: Icahn School of Medicine at Mount Sinai Files Application for 'Compositions and methods for treating EZH2-mediated cancer'

  Ramon Parsons & Jian Jin

  10/03/23

  1 item of Media coverage

  Press/Media

• Bergenbio Announces First Patient Dosed In Phase 1B/2A Trial Evaluating Bemcentinib In 1St Line Non-Small Cell Lung Cancer With STK11 Mutations

  Rajwanth Veluswamy

  9/03/23

  1 item of Media coverage

  Press/Media

• BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

  Rajwanth Veluswamy

  9/03/23

  1 item of Media coverage

  Press/Media

• BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

  Rajwanth Veluswamy

  9/03/23

  1 item of Media coverage

  Press/Media

• Protagonist Therapeutics: More Good News Likely To Come

  Yelena Ginzburg

  9/03/23

  1 item of Media coverage

  Press/Media

• Dr. Mascarenhas on the Benefit of Fedratinib in Myelofibrosis

  John Mascarenhas

  9/03/23

  1 item of Media coverage

  Press/Media

• BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

  Rajwanth Veluswamy

  9/03/23

  102 items of Media coverage

  Press/Media

• Dr. Galsky on the Rationale for the CheckMate-274 Trial in Urothelial Cancer

  Matthew Galsky

  8/03/23

  1 item of Media coverage

  Press/Media

• Dr. Mascarenhas on the Role of Pacritinib in Myelofibrosis

  John Mascarenhas

  8/03/23

  1 item of Media coverage

  Press/Media

• CheckMate 274 follow up data boost nivolumab potential for high-risk bladder cancer

  Matthew Galsky

  8/03/23

  1 item of Media coverage

  Press/Media

• Extended Follow-Up Reaffirms Benefit of Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma

  Matthew Galsky

  7/03/23

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Reports Findings in Depression (Stress-related reduction of hippocampal subfield volumes in major depressive disorder: A 7-Tesla study)

  Hung-Mo Lin, Patrick Hof, Gaurav Verma, Yael Jacob, Lazar Fleysher, James Murrough & Priti Balchandani

  7/03/23

  1 item of Media coverage

  Press/Media